Global funding for tuberculosis (TB) research reached a previously unreported high of $726 million in 2016, according to a report released today by Treatment Action Group (TAG) and the United Nations–hosted Stop TB Partnership.
The United Nations High Level Meeting (HLM) on TB is rapidly approaching. The U.N. HLM on TB will take place on September 26, 2018 during the second day of general debate of the General Assembly at its seventy-third session…
TAG and partners hosted this webinar on October 3, 2017. Speakers included Lynette Mabote, AIDS & Rights Alliance for Southern Africa; Lindiwe Mvusi, Department of Health, Republic of South Africa; Stephen Wanjala, MSF; and Wayne van Gemert, Global Drug Facility…
In advance of World TB Day, Treatment Action Group (TAG), Health GAP, AIDS-Free World and Treatment Action Campaign (TAC) urge G20 member states to commit by the July 7, 2017 G20 summit to increase annual funding contributions to USD $1.17 billion for research and development (R&D) to set us on the path to end tuberculosis (TB).
On Sunday February 12, 2017 in Seattle, the AIDS Treatment Activists Coalition, AVAC, the DARE Community Advisory Board, the defeatHIV Community Advisory Board, European AIDS Treatment Group, Project Inform and TAG co-sponsored a community workshop on HIV cure research.
December 2016 – February 2017, Updated May 2017 Examples of media coverage: Nigerian Scientists Claim To Have Discovered Complete Cure For HIV/AIDS – Nigerian Bulletin, December 13, 2016 Michael Okpara varsity discovers new cure of HIV/AIDS – Daily Trust, February…
February 2017 What are genotypes? A genotype is a way to put the hepatitis C virus (HCV) into categories based on similar genes. It’s important to know and understand HCV genotypes because different genotypes respond differently to medicines that treat…
Public health groups welcomed today’s announcement by Johns Hopkins University (JHU) and the Medicines Patent Pool (MPP) of an agreement that could expedite the research and development of a promising tuberculosis drug and lead to improved treatment options for people living with TB.
The global system for funding drug development socializes the costs and privatizes the pro ts though a system of taxpayer-funded research, legal corporate tax havens, and intellectual property registrations to guarantee exclusive access to markets and to reduce corporate taxes, while selling identical formulations at wildly different prices.
November 2016 Examples of media coverage: Israeli scientists see breakthrough in AIDS cure – The Times of Israel, November 1, 2016 Israeli researchers offer some hope for HIV carriers – Arutz Sheva 7, November 1, 2016 Israeli research successful in…